| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMDC.201600539 |
| P698 | PubMed publication ID | 28264138 |
| P50 | author | András Kotschy | Q73252492 |
| P2093 | author name string | Csaba Wéber | |
| Francisco Cruzalegui | |||
| Balázs Bálint | |||
| Mike Burbridge | |||
| P2860 | cites work | Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases | Q24316021 |
| The selectivity of protein kinase inhibitors: a further update | Q24654622 | ||
| Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors | Q27650239 | ||
| Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A | Q27665397 | ||
| The effect of deprenyl (selegiline) on the natural history of Parkinson's disease | Q28243994 | ||
| The role of DYRK1A in neurodegenerative diseases | Q34642120 | ||
| Down syndrome--recent progress and future prospects | Q34964947 | ||
| A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication | Q36402679 | ||
| MNB/DYRK1A as a multiple regulator of neuronal development | Q37820722 | ||
| Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents | Q38758935 | ||
| Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine. | Q38782393 | ||
| Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4 | Q41739576 | ||
| Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance. | Q42091667 | ||
| Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors. | Q42630760 | ||
| A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. | Q42702995 | ||
| High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain | Q46629739 | ||
| First selective dual inhibitors of tau phosphorylation and Beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer's disease | Q48523309 | ||
| Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors. | Q55071094 | ||
| Localization of monoamine oxidases in human peripheral tissues | Q61849213 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 932-939 | |
| P577 | publication date | 2017-04-06 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition | |
| P478 | volume | 12 |
| Q96958956 | A Dual Inhibitor of DYRK1A and GSK3β for β-Cell Proliferation: Aminopyrazine Derivative GNF4877 |
| Q90610025 | Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation |
| Q54107922 | Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase. |
Search more.